Abstract:Diagnosis and treatment forof congenital V factor deficiency. PT, prothrombin time; APTT, activated partial thromboplastin time; F I D, Hhereditary fibrinogen deficiency; F II D, Pprothrombin deficiency; F V D, coagulation factor V deficiency; F X D, coagulation factor X deficiency; F V + VIII D, combined deficiency of factors V and VIII; VKDFD, Vitamin K‐dependent coagulation factor deficiency; DIC, Ddisseminated intravascular coagulation; FFP, fresh frozen plasma; rFVIIa, recombinant activated coagulation factor VII. Background Congenital coagulation factor V (FV) deficiency is a very rare hemorrhagic disease with an incidence of approximately one in a million. The common clinical manifestations of FV deficiency include ecchymosis and mucosal bleeding. Life‐threatening intracranial bleeding is rare. It has been reported in several cases. However, the molecular basis has been established in only a few cases. Methods We reported a 2‐month‐old girl with congenital FV deficiency and intracranial hemorrhage. Coagulation screening combined with clinical manifestations was performed to diagnose congenital FV deficiency. Genetic testing was performed to identify the pathogenic genes. A literature review was included to emphasize the clinical manifestation, diagnosis, and treatment for congenital FV deficiency with intracranial bleeding. Results The coagulation tests revealed a significantly prolonged prothrombin time (PT) of 51 s and an activated partial thromboplastin time (APTT) of 73.7 s. The patient had a plasma FV activity of 0.9%. Genetic testing showed compound heterozygous mutations of the patient's FV gene. A literature review showed that patients with homozygous or compound heterozygous variants of the FV gene were often associated with a severe bleeding phenotype. Conclusion Our study provides a direction for the rapid and accurate diagnosis and treatment for FV deficiency to avoid life‐threatening bleeding. Infants with spontaneous cranial hematoma and intracranial hemorrhage should be investigated for underlying hemostatic defects. Congenital coagulation factor deficiency should be considered. Once congenital FV deficiency is diagnosed, fresh frozen plasma (FFP) should be given on a regular basis. Liver transplantation may be performed in severe cases.

Acquired Factor V Deficiency in a Patient with a Urinary Tract Infection Presenting with Haematuria Followed by Multiple Haemorrhages with an Extremely Low Level of Factor V Inhibitor: a Case Report and Review of the Literature.

Acquired Factor V Inhibitor with Lupus-Like Features

Successful Laparoscopic Common Bile Duct Exploration in A Patient with Factor V Deficiency, A Case Report and Review of Literature

Acquired hemophilia A with venous thrombosis:report of a case and review of the literature

Acquired Factor V Deficiency Associated with CFPM Administration

[Congenital Factor X Deficiency: a Retrospective Analysis of 11 Cases].

[Congenital factor VII deficiency: a retrospective analysis of 43 cases].

Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.

A Case of Unusual Acquired Factor V Deficiency

A Rare Case of Hemophilia: Acquired Factor VIII Deficiency

Acquired hemophilia A in the setting of dual anticoagulation therapy and lupus anticoagulant: a case report

Acquired factor XIII deficiency presenting with multiple intracranial hemorrhages and right hip hematoma: A case report

A Rare Case of Acquired Factor VIII Deficiency in an Elderly Male With a History of Rheumatoid Arthritis

Acquired Multiple Coagulation Factor Inhibitors Associated Bleeding Disorder

Acquired Hemophilia A Patients: Clinical Experience of 12 Cases

Congenital coagulation factor V deficiency with intracranial hemorrhage

Acquired Hemophilia A Diagnosed Based on Gross Hematuria: A Case Report and Literature Review

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Acquired hemophilia A: a single-center study of 165 patients

[Elucidation of an altered anticoagulant function due to Factor V abnormality and development of a simple screening assay for thrombophilia]

Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency